obsevation
Otherprospective data collection for colonic or rectal surgery
NCT Number: NCT04704817
Colorectal cancer is the third most common cancer in men, after prostate and lung cancer. It represents 11.2% of all new cases of male cancer. In women, this cancer is the second most common after breast cancer (11.3% of all new cases of female cancer).
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Colorectal cancer is the second leading cause of cancer death in France. It accounts for nearly 12% of all cancer deaths, especially among those 65 and over. However, mortality has declined steadily since 1980.
Access to screening for colorectal cancer and resection of precancerous lesions partly explains this decline. All sexes combined, it is estimated that about one in five colorectal cancer is diagnosed at a limited local stage. The treatment is then less heavy and gives better results.
With the development of Enhanced Recovery After Surgery (ERAS) protocols and their extension to rectal excision, it becomes imperative to be able to collect operative data from these patients on a perennial basis for the purpose of evaluating our results. Finally, the evaluations resulting from this database could have prognostic value and ultimately allow us to adapt the surgical management of the patient according to the results.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
prospective data collection for colonic or rectal surgery
Time frame: 5 years
to asses postoperative effects of colonic or rectal excision by collecting clinical events
Institut Paoli-Calmettes
Other
Acronym: CHIRCOLREC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06531226
Colorectal Disorders
Jinan, Shandong, China
View Trial DetailsNCT03862781
Colorectal Disorders
Grand Rapids, Michigan, United States
View Trial DetailsNCT06342440
Colonic Diseases, Colonic Neoplasms
Monrovia, California, United States
View Trial DetailsNCT06356558
Behavior, Colorectal Disorders
Birmingham, Alabama, United States
View Trial Details